Abstract: Objective :The prognosis of patients with adenocarcinoma is not as good as squamous cell carcinoma. During the last a few decades, the incidence of adenocarcinoma tends to increasing and a higher morbidity among young women. To determine the prognostic factors, the rate of ovarian metastasis and the treatment modality of adenocarcinoma, ranking second in the common malignancy of the uterine cervix following squamous cell carcinoma. Methods A total of 105 cases with primary adenocarcinomas, diagnosed and treated during 1970 to 2002 in the cancer center, were studied retrospectively. Clinical and pathological data were reviewed and analyzed. Results : Mean age of the patients during 1970 to 1986 was 50, and it was 46 during 1987 to 2002. The 5-year survival rate for stages Ⅰ, Ⅱ and Ⅲ was 58.24%, 49.48% and 21.20%, respectively. Both univariate and multivariate analysis revealed that tumor size and lymph node metastases were significant prognostic factors. According to patients diagnosed with stage Ⅱ, different 5-year survival rates among the treatment modalities have a statistical significance. The therapy of surgery group and of adjuvant radiotherapy after surgery group resulted in a better prognosis than that of others (P=0.004 1). A total of 68 patients underwent bilateral salpingooophorectomy. Three of them (4.41%) had ovarian metastases. Conclusion : The age of the adenocarcinoma patients tends to decreasing. Patients with adenocarcinoma have a worse prognosis as compared to those with squamous carcinoma. Bulky tumor and lymph node metastases are significant prognostic factors for survival in cervical adenocarcinoma. Our data imply that surgery may result in a better prognosis than radiotherapy, and advance adenocarcinoma has a higher ovarian metastases. However, unilateral normal ovary can be preserved for the young women with early-stage adenocarcinoma.